GHK-Cu (100 mg Vial) Dosage Protocol

Dosing & Reconstitution Overview

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK), a small signalling molecule first isolated from human plasma. The figures below are compiled strictly for laboratory and educational reference — they describe how the compound has been handled and dosed in published regenerative and skin-matrix research, not a recommendation for use in humans or animals.

For a 100 mg vial, adding 3.0 mL of bacteriostatic water yields a concentration of roughly 33.3 mg/mL (≈33,333 mcg/mL). At that fill, every 0.03 mL drawn on a U-100 insulin syringe equals 3 units and delivers about 1 mg of material, which keeps the small-volume arithmetic manageable across the titration steps.

Standard (Gradual) Titration Schedule

The gradual schedule steps the daily amount upward in four-week blocks, a common laboratory pattern that introduces the lowest effective quantity first before advancing. Dosing in the source model runs five days per week (Monday–Friday) with weekends left as a washout.

Reconstitution Steps

1. Let the sealed lyophilized vial and the bacteriostatic water reach room temperature, then wipe both stoppers with an alcohol swab.
2. Draw 3.0 mL of bacteriostatic water with a sterile syringe and inject it slowly down the inside wall of the vial — never directly onto the powder pellet.
3. Swirl or roll gently until the deep-blue solution is fully dissolved. Do not shake; vigorous agitation foams and can shear the peptide.
4. The reconstituted solution carries the characteristic blue tint of the copper complex. Label the vial with the concentration (~33.3 mg/mL) and the reconstitution date.
5. Refrigerate at 2–8 °C protected from light between uses, and draw subsequent volumes with a fresh sterile syringe each time.

Reference Daily-Volume Table

Because GHK-Cu is dosed in very small fractions of a millilitre, the table below restates each titration step as the exact syringe reading on a U-100 insulin syringe at the ~33.3 mg/mL fill, to reduce measuring error at these low volumes.

Supplies Needed

• GHK-Cu vials (100 mg): 1 vial covers a full 8–12 week schedule dosing five days per week at 1–2 mg.
• Insulin syringes (U-100, 30- or 50-unit): roughly 40–60 for an 8–12 week run, using one fresh syringe per draw.
• Bacteriostatic water (10 mL): one bottle is more than sufficient for the single 3 mL reconstitution.
• Alcohol swabs: about 80–120 (one to two 100-count boxes) across the schedule.

Protocol Overview

• Research goal: model tissue remodelling, collagen-matrix and copper-cofactor signalling.
• Schedule: once-daily subcutaneous administration, five days per week in the published model.
• Dose band: 1–2 mg daily, titrated gradually across 12 weeks.
• Fill: 100 mg lyophilized, reconstituted to ~33.3 mg/mL with 3 mL diluent.
• Storage: −20 °C dry; 2–8 °C once reconstituted.

Dosing Protocol Notes

• Begin at the 1 mg step and hold each level for about four weeks before advancing.
• The five-on / two-off weekly cadence in the source model leaves a consistent washout window.
• Escalate to the next step only after tolerability is established at the prior level.
• The deep-blue colour of the solution is normal for the copper complex and is not a sign of degradation.

Storage Instructions

Keep sealed lyophilized vials at −20 °C, protected from light, where stability extends for twelve months or more. Once reconstituted, refrigerate at 2–8 °C and use within about 30 days. Protect the solution from light, allow it to warm slightly before drawing, and avoid repeated freeze-thaw cycles, which can degrade the peptide.

Important Handling Notes

• Use a sterile syringe for every draw and never re-enter the vial with a used needle.
• Measure carefully — at 1–2 mg the working volumes are only 0.03–0.06 mL, so small errors are proportionally large.
• Keep the reconstituted vial shielded from light to preserve the copper complex.
• Document each draw — date, volume, remaining material — for reproducibility.

How GHK-Cu Works

GHK-Cu acts as a signal peptide that chelates copper(II) and shuttles the ion to cells, where it serves as a cofactor for enzymes such as lysyl oxidase (collagen cross-linking) and superoxide dismutase (antioxidant defence). In published cell and tissue models the complex shifts gene expression toward regenerative phenotypes, stimulates fibroblast production of VEGF and bFGF, supports angiogenesis, raises synthesis of collagen, elastin and glycosaminoglycans, and modulates matrix metalloproteinases involved in tissue remodelling. This copper-delivery role is what distinguishes it from peptides that act primarily through receptor agonism.

Reported Benefits & Side Effects

Effects observed in research

• Increased dermal collagen density, greater measured skin thickness and reduced wrinkle depth in skin models.
• Accelerated wound-closure markers via angiogenesis and granulation-tissue formation.
• Suppression of pro-inflammatory cytokines such as TNF-α and IL-6 in inflammatory models.
• Enlarged hair-follicle size and increased growth rate in follicle studies.

Side effects reported

• Occasional mild injection-site reactions such as transient redness or stinging.
• An overall favourable tolerability profile with a wide reported safety margin and no serious adverse effects in the cited work.

Injection / Handling Technique (Reference Only)

• Wipe the vial stopper and the chosen site with alcohol and let both dry.
• Pinch a skinfold and insert subcutaneously at a 45–90° angle depending on needle length; aspiration is not required for subcutaneous work.
• Inject slowly and steadily, then wait 5–10 seconds before withdrawing the needle.
• Rotate sites systematically (abdomen, thighs, upper arms) and dispose of sharps in an approved container.

References

Related Protocols